General
New Mexico Department of Health Seeks Clinician Enrollment in ILINet
Health Emergency Management - General
September 14, 2023
New Mexico Department of Health Seeks Clinician Enrollment in ILINet
Letter from Governor Michelle Lujan Grisham to U.S. Attorney General Merrick Garland
Injury Prevention - General
September 11, 2023
Letter from Governor Michelle Lujan Grisham to U.S. Attorney General Merrick Garland
Governors Proclamation Falls Prevention Awareness Week, Sept 18-22, 2023
Injury Prevention - General
September 1, 2023
Governors Proclamation Falls Prevention Awareness Week, Sept 18-22, 2023
Governors Proclamation Suicide Prevention Month 2023
Injury Prevention - General
August 31, 2023
Governors Proclamation Suicide Prevention Month 2023
Pneumococcal Disease Factsheet (English)
Infectious Disease Surveillance - General
August 29, 2023
Pneumococcal Disease Factsheet (English)
Pneumococcal Disease Factsheet (Spanish)
Infectious Disease Surveillance - General
August 29, 2023
Pneumococcal Disease Factsheet (Spanish)
Health Promotion Team – SE Region Legislative Fact Sheet
Health Promotion - General
August 28, 2023
This document explains the mission statement, core values, and health promotion team vision of the Southeast Region Health Promotion Team. Staff and contact information listing.
Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023
Health Emergency Management - General
August 28, 2023
Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023
Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Sexually Transmitted Infections
Health Emergency Management - General
August 28, 2023
Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Sexually Transmitted Infections
COVID-19 Update - Paxlovid Prescribing - August 24, 2023
Health Emergency Management - General
August 28, 2023
As the number of COVID-19 cases rises across the US, the New Mexico Department of Health recommends that providers prescribe Paxlovid (nirmatrelvir/ritonavir) to all appropriate patients diagnosed with COVID-19. Paxlovid, an oral antiviral, is a highly effective treatment for COVID-19 but continues to be under prescribed by providers1. Support for the use of Paxlovid comes from several randomized trials and observational studies of symptomatic outpatients with COVID-19, which demonstrated a reduction in hospitalization and death.
LLCP Mission Vision Values handout
Los Lunas Community Program - General
July 21, 2023
LLCP Mission Vision Values handout
NMHSC Stipend Reference Letter for 2023
Primary Care & Rural Health - General
July 12, 2023
NMHSC Stipend Reference Letter for 2023
Talking with Your Children About Cannabis
Rules & Regulations - General
July 12, 2023
Talking with Your Children About Cannabis
New HIV infections associated with former VIP Spa in Albuquerque - June 26, 2023
Health Emergency Management - General
June 28, 2023
New HIV infections associated with former VIP Spa in Albuquerque - June 26, 2023
Patient Changes Letter - 06/16/2023
Patients & Caregivers - General
June 21, 2023
Changes to enrollment cards starting June 16, 2023
New Fingerprinting Service Provider IdentoGO FAQs May 2023
Community Health Workers - General
May 30, 2023
New Fingerprinting Service Provider IdentoGO FAQs May 2023
Governors Proclamation Gun Violence Awareness Month 2023
Injury Prevention - General
May 25, 2023
Governors Proclamation Gun Violence Awareness Month 2023
Increased Numbers of Hantavirus Cases in New Mexico in 2023 - May 24, 2023
Health Emergency Management - General
May 24, 2023
The New Mexico Department of Health has identified five cases of Hantavirus Pulmonary Syndrome (HPS) in New Mexico residents in the first five months of 2023, already exceeding the average annual case count.